{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T17:02:25Z","timestamp":1791910945361,"version":"4.3.4"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.eplepsyres.2022.106866","type":"journal-article","created":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T11:35:50Z","timestamp":1642678550000},"page":"106866","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Electrocorticographic and electrocardiographic evaluation of lacosamide in a penicillin-induced status epilepticus model"],"prefix":"10.1016","volume":"180","author":[{"given":"Orhan","family":"Sumbul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatice","family":"Aygun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2022.106866_bib1","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/795259","article-title":"Oxidative stress and epilepsy: literature review","volume":"2012","author":"Aguiar","year":"2012","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.eplepsyres.2022.106866_bib2","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.3892\/etm.2015.2794","article-title":"Novel antiepileptic drug lacosamide exerts neuroprotective effects by decreasing glial activation in the hippocampus of a gerbil model of ischemic stroke","volume":"10","author":"Ahn","year":"2015","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.eplepsyres.2022.106866_bib3","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.neuint.2018.08.007","article-title":"Pregabalin and lacosamide ameliorate paclitaxel-induced peripheral neuropathy via inhibition of JAK\/STAT signaling pathway and Notch-1 receptor","volume":"120","author":"Al-Massri","year":"2018","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.eplepsyres.2022.106866_bib4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.yebeh.2019.03.050","article-title":"The effect of fluoxetine on penicillin-induced epileptiform activity","volume":"95","author":"Aygun","year":"2019","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2022.106866_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2019.106847","article-title":"Trazodone increases seizures in a genetic WAG\/Rij rat model of absence epilepsy while decreasing them in penicillin-evoked focal seizure model","volume":"103","author":"Aygun","year":"2020","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2022.106866_bib6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0920-1211(01)00302-3","article-title":"Pharmacological characterization of the 6 Hz psychomotor seizure model of partial epilepsy","volume":"47","author":"Barton","year":"2001","journal-title":"Epilepsy Res."},{"issue":"7","key":"10.1016\/j.eplepsyres.2022.106866_bib7","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/j.1528-1167.2007.01188.x","article-title":"Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures","volume":"48","author":"Ben-Menachem","year":"2007","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.eplepsyres.2022.106866_bib8","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1177\/0897190017700557","article-title":"Lacosamide-induced recurrent ventricular tachycardia in the acute care setting","volume":"31","author":"Berei","year":"2018","journal-title":"J. Pharm. Pract."},{"issue":"5","key":"10.1016\/j.eplepsyres.2022.106866_bib9","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.neuropharm.2007.01.012","article-title":"Antihyperalgesic efficacy of lacosamide in a rat model for muscle pain induced by TNF","volume":"52","author":"Beyreuther","year":"2007","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.eplepsyres.2022.106866_bib10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1586\/14737175.9.1.33","article-title":"Lacosamide: pharmacology, mechanisms of action and pooled efficacy and safety data in partial-onset seizures","volume":"9","author":"Beydoun","year":"2009","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.eplepsyres.2022.106866_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2015.09.006","article-title":"Safety and tolerability of lacosamide as adjunctive therapy for adults with partial-onset seizures: Analysis of data pooled from three randomized, double-blind, placebo-controlled clinical trials","volume":"52","author":"Biton","year":"2015","journal-title":"Epilepsy Behav."},{"issue":"4","key":"10.1016\/j.eplepsyres.2022.106866_bib12","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2165\/11636260-000000000-00000","article-title":"Efficacy and tolerability of lacosamide in the concomitant treatment of 130 patients under 16 years of age with refractory epilepsy","volume":"12","author":"Casas-Fern\u00e1ndez","year":"2012","journal-title":"Drugs RD"},{"key":"10.1016\/j.eplepsyres.2022.106866_bib13","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1001\/jamaneurol.2017.3949","article-title":"Treatment outcomes in patients with newly diagnosed epilepsy treated With established and new antiepileptic drugs: A 30-year longitudinal cohort study","volume":"75","author":"Chen","year":"2018","journal-title":"JAMA Neurol."},{"issue":"6","key":"10.1016\/j.eplepsyres.2022.106866_bib14","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1111\/epi.12108","article-title":"Sinus node dysfunction: an adverse effect of lacosamide","volume":"54","author":"Chinnasami","year":"2013","journal-title":"Epilepsia"},{"issue":"9","key":"10.1016\/j.eplepsyres.2022.106866_bib15","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1007\/s11064-016-1951-8","article-title":"Increases of catalase and glutathione peroxidase expressions by lacosamide pretreatment contributes to neuroprotection against experimentally induced transient cerebral ischemia","volume":"41","author":"Choi","year":"2016","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.eplepsyres.2022.106866_bib16","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3340\/jkns.2019.0178","article-title":"Neuroprotective effects of lacosamide in experimental peripheral nerve injury in rats: a prospective randomized and placebo-controlled trial","volume":"63.2","author":"Demiroz","year":"2020","journal-title":"J. Korean Neurosurg. Soc."},{"issue":"1","key":"10.1016\/j.eplepsyres.2022.106866_bib17","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/nyas.12213","article-title":"Development of lacosamide for the treatment of partial-onset seizures","volume":"1291","author":"Doty","year":"2013","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"18","key":"10.1016\/j.eplepsyres.2022.106866_bib18","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000025577","article-title":"Lacosamide induced Brugada I morphology in the setting of septicemia: a case report","volume":"100","author":"Goodnough","year":"2021","journal-title":"Medicine"},{"issue":"3","key":"10.1016\/j.eplepsyres.2022.106866_bib19","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1528-1167.2008.01951.x","article-title":"Adjunctive lacosamide for partial-onset seizures: efficacy and safety results from a randomized controlled trial","volume":"50","author":"Halasz","year":"2009","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.eplepsyres.2022.106866_bib20","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/epi.12017","article-title":"Cardiac injury in refractory status epilepticus","volume":"54","author":"Hocker","year":"2013","journal-title":"Epilepsia"},{"issue":"12","key":"10.1016\/j.eplepsyres.2022.106866_bib21","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s40263-013-0123-5","article-title":"Lacosamide: a review of its use as adjunctive therapy in the management of partial-onset seizures","volume":"27","author":"Hoy","year":"2013","journal-title":"CNS Drugs"},{"key":"10.1016\/j.eplepsyres.2022.106866_bib22","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3988\/jcn.2017.13.2.138","article-title":"Neuroprotective effect of lacosamide on hypoxic-ischemic brain injury in neonatal rats","volume":"13.2","author":"Kim","year":"2017","journal-title":"J. Clin. Neurol."},{"issue":"6","key":"10.1016\/j.eplepsyres.2022.106866_bib23","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/j.1528-1167.2009.02463.x","article-title":"Intravenous lacosamide as shortterm replacement for oral lacosamide in partial-onset seizures","volume":"51","author":"Krauss","year":"2010","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.eplepsyres.2022.106866_bib24","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/ane.12416","article-title":"Lacosamide cardiac safety: a thorough QT\/QTc trial in healthy volunteers","volume":"132","author":"Kropeit","year":"2015","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.eplepsyres.2022.106866_bib25","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.seizure.2015.03.003","article-title":"Lacosamide monotherapy for partial onset seizures","volume":"27","author":"Lattanzi","year":"2015","journal-title":"Seizure"},{"issue":"2","key":"10.1016\/j.eplepsyres.2022.106866_bib26","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/fcp.12598","article-title":"Lacosamide improves biochemical, genotoxic, and mitochondrial parameters after PTZ\u2010kindling model in mice","volume":"35","author":"Lazzarotto","year":"2021","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.eplepsyres.2022.106866_bib27","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/14740338.2020.1713089","article-title":"The adverse-effect profile of lacosamide","volume":"19","author":"Li","year":"2020","journal-title":"Expert Opin. Drug Saf."},{"issue":"7","key":"10.1016\/j.eplepsyres.2022.106866_bib28","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/epi.12196","article-title":"Lacosamide treatment following status epilepticus attenuates neuronal cell loss and alterations in hippocampal neurogenesis in a rat electrical status epilepticus model","volume":"54","author":"Licko","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2022.106866_bib29","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0920-1211(02)00073-6","article-title":"Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. a comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy","volume":"50","author":"Loescher","year":"2002","journal-title":"Ep Res."},{"key":"10.1016\/j.eplepsyres.2022.106866_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/jcph.1840","article-title":"Use of real\u2010world data and pharmacometric modeling in support of lacosamide dosing in pediatric patients under 4 years of age","author":"Lukka","year":"2021","journal-title":"J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.eplepsyres.2022.106866_bib31","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3109\/15563650.2013.778993","article-title":"Fatal lacosamide poisoning in relation to cardiac conduction impairment and cardiovascular failure","volume":"51","author":"Malissin","year":"2013","journal-title":"Clin. Toxicol."},{"issue":"12","key":"10.1016\/j.eplepsyres.2022.106866_bib32","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1111\/epi.13224","article-title":"A noninterventional study evaluating the effectiveness and safety of lacosamide added to monotherapy in patients with epilepsy with partial-onset seizures in daily clinical practice: the VITOBA study","volume":"56","author":"Runge","year":"2015","journal-title":"Epilepsia"},{"issue":"9","key":"10.1016\/j.eplepsyres.2022.106866_bib33","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.3390\/ijms22094667","article-title":"Effects of lacosamide treatment on epileptogenesis, neuronal damage and behavioral comorbidities in a rat model of temporal lobe epilepsy","volume":"22","author":"Shishmanova-Doseva","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.eplepsyres.2022.106866_bib34","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1179\/1743132815Y.0000000040","article-title":"Demonstration of ameliorative effect of lacosamide: in a rat model of sepsis-induced critical illness polyneuropathy","volume":"37","author":"Solmaz","year":"2015","journal-title":"Neurol. Res."},{"issue":"2\u20133","key":"10.1016\/j.eplepsyres.2022.106866_bib35","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.eplepsyres.2007.03.004","article-title":"Lacosamide, a novel anti-convulsant drug, shows efficacy with a wide safety margin in rodent models for epilepsy","volume":"74","author":"St\u00f6hr","year":"2007","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2022.106866_bib36","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.brainresbull.2019.01.017","article-title":"Agomelatine alleviates neuronal loss through BDNF signaling in the post-status epilepticus model induced by kainic acid in rat","volume":"147","author":"Tchekalarova","year":"2019","journal-title":"Brain Res. Bull."},{"issue":"2","key":"10.1016\/j.eplepsyres.2022.106866_bib37","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1600-0404.1997.tb00242.x","article-title":"ECG changes in epilepsy patients","volume":"96","author":"Tigaran","year":"1997","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.eplepsyres.2022.106866_bib38","unstructured":"UCB Pharma. Vimpat\u00ae (Lacosamide) US Prescribing Information. Smyrna, GA: UCB, Inc. \u3008https:\/\/www.ucb.com\/_up\/ucb_com_products\/documents\/VIMPAT_current_COL_November_2020.pdf\u3009. Published 2020. (Accessed January 31, 2021)."},{"issue":"2","key":"10.1016\/j.eplepsyres.2022.106866_bib39","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00401-015-1481-5","article-title":"Infections, inflammation and epilepsy","volume":"131","author":"Vezzani","year":"2016","journal-title":"Acta Neuropathol."},{"issue":"10","key":"10.1016\/j.eplepsyres.2022.106866_bib40","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1111\/epi.13502","article-title":"Long-term exposure and safety of lacosamide monotherapy for the treatment of partial-onset (focal) seizures: results from a multicenter, open-label trial","volume":"57","author":"Vossler","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2022.106866_bib41","series-title":"Treatment of Epilepsy","first-page":"641","article-title":"Lacosamide","author":"Wechsler","year":"2021"},{"key":"10.1016\/j.eplepsyres.2022.106866_bib42","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.eplepsyres.2019.03.011","article-title":"Mode of seizure inhibition by sodium channel blockers, an SV2A ligand, and an AMPA receptor antagonist in a rat amygdala kindling model","volume":"154","author":"Wu","year":"2019","journal-title":"Epilepsy Res."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121122000171?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121122000171?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:46:22Z","timestamp":1760276782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121122000171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":42,"alternative-id":["S0920121122000171"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2022.106866","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Electrocorticographic and electrocardiographic evaluation of lacosamide in a penicillin-induced status epilepticus model","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2022.106866","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106866"}}